Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C, Larrivée B.
Angiogenesis. 2017 Nov;20(4):409-426. doi: 10.1007/s10456-017-9562-9. Epub 2017 Jun 28.
Basic and Therapeutic Aspects of Angiogenesis Updated.
Eelen G, Treps L, Li X, Carmeliet P.
Circ Res. 2020 Jul 3;127(2):310-329. doi: 10.1161/CIRCRESAHA.120.316851. Epub 2020 Jul 2.
Normalization of the vasculature for treatment of cancer and other diseases.
Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK.
Physiol Rev. 2011 Jul;91(3):1071-121. doi: 10.1152/physrev.00038.2010.
Pericyte signaling via soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors.
Zhu J, Yang W, Ma J, He H, Liu Z, Zhu X, He X, He J, Chen Z, Jin X, Wang X, He K, Wei W, Hu J.
EMBO J. 2024 Apr;43(8):1519-1544. doi: 10.1038/s44318-024-00078-5. Epub 2024 Mar 25.
Vascular damaging agents.
Patterson DM, Rustin GJ.
Clin Oncol (R Coll Radiol). 2007 Aug;19(6):443-56. doi: 10.1016/j.clon.2007.03.014. Epub 2007 Apr 24.
Vascular remodeling in cancer.
Farnsworth RH, Lackmann M, Achen MG, Stacker SA.
Oncogene. 2014 Jul 3;33(27):3496-505. doi: 10.1038/onc.2013.304. Epub 2013 Aug 5.
Mouse models of vascular development and disease.
Cleaver O.
Curr Opin Hematol. 2021 May 1;28(3):179-188. doi: 10.1097/MOH.0000000000000649.
Kruppel-like factors and vascular wall homeostasis.
Fan Y, Lu H, Liang W, Hu W, Zhang J, Chen YE.
J Mol Cell Biol. 2017 Oct 1;9(5):352-363. doi: 10.1093/jmcb/mjx037.
Spotlight on mechanisms of vascular inflammation.
Sanchez-Madrid F, Sessa WC.
Cardiovasc Res. 2010 May 1;86(2):171-3. doi: 10.1093/cvr/cvq083. Epub 2010 Mar 13.
Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.
Yu B, Wang S.
Theranostics. 2018 Jun 8;8(13):3654-3675. doi: 10.7150/thno.26024. eCollection 2018.
